Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Powles

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
ESMO Open|May 24, 2025
Health-related quality-of-life profile and clinical outcomes in first-line advanced renal cell carcinoma: a modeling analysis based on the CheckMate 9ER studyD Cella, M Derosa, L Floden, et al.
ESMO Open|March 22, 2023
Safety and efficacy of cobimetinib plus atezolizumab in patients with solid tumors: a phase II, open-label, multicenter, multicohort studyE Sherman, J L Lee, P R Debruyne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
Multicenter study of human immunodeficiency virus-related germ cell tumorsT Powles, M Bower, G Daugaard, et al.
British Journal of Cancer|April 15, 2004
Outcome of patients with HIV-related germ cell tumours: a case-control studyT Powles, M Bower, J Shamash, et al.
British Journal of Cancer|July 5, 2007
GAMEC--a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumoursJ Shamash, T Powles, W Ansell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
Increased haematopoietic progenitor cells are associated with poor outcome in patients with metastatic renal cancer treated with sunitinibT Powles, S Chowdhury, J Shamash, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2011
The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancerT Powles, I Kayani, C Blank, et al.
Cancer Immunology, Immunotherapy : CII|March 9, 2005
Phase I study of TNFalpha AutoVaccIne in patients with metastatic cancerA M Waterston, L Gumbrell, T Bratt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2023
EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinomaJ E Rosenberg, T Powles, G P Sonpavde, et al.
ESMO Open|July 8, 2026
A phase Ib/II, open-label, multicenter, randomized umbrella study evaluating the combination of atezolizumab with sacituzumab govitecan in patients with locally advanced or metastatic urothelial carcinoma and previously treated with a platinum-based treatment regimen (MORPHEUS-Urothelial Carcinoma)S J Shin, J L Lee, T Powles, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
ESMO Open|May 24, 2025
Health-related quality-of-life profile and clinical outcomes in first-line advanced renal cell carcinoma: a modeling analysis based on the CheckMate 9ER studyD Cella, M Derosa, L Floden, et al.
ESMO Open|March 22, 2023
Safety and efficacy of cobimetinib plus atezolizumab in patients with solid tumors: a phase II, open-label, multicenter, multicohort studyE Sherman, J L Lee, P R Debruyne, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
Multicenter study of human immunodeficiency virus-related germ cell tumorsT Powles, M Bower, G Daugaard, et al.
British Journal of Cancer|April 15, 2004
Outcome of patients with HIV-related germ cell tumours: a case-control studyT Powles, M Bower, J Shamash, et al.
British Journal of Cancer|July 5, 2007
GAMEC--a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumoursJ Shamash, T Powles, W Ansell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
Increased haematopoietic progenitor cells are associated with poor outcome in patients with metastatic renal cancer treated with sunitinibT Powles, S Chowdhury, J Shamash, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2011
The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancerT Powles, I Kayani, C Blank, et al.
Cancer Immunology, Immunotherapy : CII|March 9, 2005
Phase I study of TNFalpha AutoVaccIne in patients with metastatic cancerA M Waterston, L Gumbrell, T Bratt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 7, 2023
EV-301 long-term outcomes: 24-month findings from the phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated advanced urothelial carcinomaJ E Rosenberg, T Powles, G P Sonpavde, et al.
ESMO Open|July 8, 2026
A phase Ib/II, open-label, multicenter, randomized umbrella study evaluating the combination of atezolizumab with sacituzumab govitecan in patients with locally advanced or metastatic urothelial carcinoma and previously treated with a platinum-based treatment regimen (MORPHEUS-Urothelial Carcinoma)S J Shin, J L Lee, T Powles, et al.
Pageof 9